Companies:
50,690
Total Market Cap:
149419522938903.31
Global Rank
#12797
Country Rank
#3835
Market Cap
659.19 M
Price
5.04
Change (%)
3.79%
Volume
8.55 M
Wuhan Hiteck Biological Pharma Co.,Ltd's latest marketcap:
659.19 M
As of 09/23/2025, Wuhan Hiteck Biological Pharma Co.,Ltd's market capitalization has reached $659.19 M. According to our data, Wuhan Hiteck Biological Pharma Co.,Ltd is the 12797th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 659.19 M |
| Revenue (ttm) | 89.9 M |
| Net Income (ttm) | -12,057,762.1 |
| Shares Out | 130.89 M |
| EPS (ttm) | -0.09 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 01/09/2025 |
| Earnings Date | 08/26/2025 |
Market Cap Chart
Data Updated: 09/23/2025
Wuhan Hiteck Biological Pharma Co.,Ltd's yearly market capitalization.
Wuhan Hiteck Biological Pharma Co.,Ltd has seen its market value drop from ¥5.64 B to ¥4.69 B since 2017, representing a total decrease of 16.92% and an annual compound decline rate (CAGR) of 2.37%.
| Date | Market Cap(¥) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 09/23/2025 | ¥4.69 B | $659.19 M | 56.21% | 12797 |
| 12/31/2024 | ¥3.12 B | $427.36 M | -33.98% | 14019 |
| 12/29/2023 | ¥4.73 B | $665.69 M | 9.35% | 11097 |
| 12/30/2022 | ¥4.32 B | $626.33 M | -40.56% | 10851 |
| 12/31/2021 | ¥7.27 B | $1.14 B | 72.12% | 8635 |
| 12/31/2020 | ¥4.23 B | $647.25 M | 35.86% | 10203 |
| 12/31/2019 | ¥3.11 B | $446.59 M | 10.42% | 10597 |
| 12/28/2018 | ¥2.82 B | $409.51 M | -50.09% | 10131 |
| 12/29/2017 | ¥5.64 B | $866.79 M | 7793 |
Company Profile
About Wuhan Hiteck Biological Pharma Co., Ltd.
Wuhan Hiteck Biological Pharma Co., Ltd. is a biopharmaceutical company specializing in the research, development, production, and sale of bioengineering products and freeze-dried powder injections in China.
Key Products
- Anewway – Mouse nerve growth factor for injection.
- Omeprazole Sodium for Injection – Used for duodenal ulcer, gastric ulcer, reflux esophagitis, and Zollinger-Ellison syndrome.
- Adenosine Cyclophosphate for Injection – Treats angina pectoris, myocardial infarction, myocarditis, and cardiogenic shock.
- Aciclovir Dispersible Tablets – Targets genital herpes virus infection, herpes zoster, and immune deficiency chickenpox.
- Indometacin and Furazolidone Suppositories – Addresses internal/external hemorrhoids, anal swelling, and anorectal diseases.
- Tinidazole Suppositories – For trichomonas vaginitis and bacterial vaginosis.
- Nimodipine Sustained Release Tablets – Used for ischemic cerebrovascular disease, migraine, and cerebral vasospasm.
- Trimetazidine Dihydrochloride Tablets – Treats stable angina.
- Azithromycin Granules – For acute pharyngitis, tonsillitis, and bronchitis.
Diagnostic Kits
- Measles and rubella virus nucleic acid detection kit.
- Mycoplasma isolation and identification tube/kit.
- Bacterial vaginosis (BV) rapid test kit.
- Novel coronavirus N-Protein diagnostic kit.
- Diagnostic kits for IgG/IgM antibodies (measles virus, herpes simplex virus, cytomegalovirus, rubella virus, toxoplasma).
- α-Thalassemia diagnostic kit.
Additional Offerings
- Lopinavir and Ritonavir APIs.
- Pharmaceutical intermediates.
The company primarily serves the nervous system and oncology sectors. Founded in 1992, Wuhan Hiteck Biological Pharma Co., Ltd. is headquartered in Wuhan, China.
Frequently Asked Questions
-
What is Wuhan Hiteck Biological Pharma Co.,Ltd's (SHE-300683) current market cap?As of 09/23/2025, Wuhan Hiteck Biological Pharma Co.,Ltd (including the parent company, if applicable) has an estimated market capitalization of $659.19 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Wuhan Hiteck Biological Pharma Co.,Ltd (SHE-300683) rank globally by market cap?Wuhan Hiteck Biological Pharma Co.,Ltd global market capitalization ranking is approximately 12797 as of 09/23/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.